ADublin-based medical diagnostics company has announced that it is pursuing a €5 million funding round in order to finance development of a new test for osteoporosis.
Crescent Diagnostics, which is based in UCD's technology transfer centre NovaUCD, has developed a new test which it calls BQT.
The test involves analysing the chemical bonds in a small toenail clipping, which Crescent's research has shown to be strongly predictive of future hip fractures, the most serious of...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team